drug · small molecule
tivozanib
Phase 2updated 3mo agoby Kyowa Kirin Co Ltd🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for renal cell carcinoma and neoplasm and 10 investigational indications.
indications
indications
Diabetic Macular Edema
targets
Platelet-derived growth factor receptor betaVascular endothelial growth factor receptorMast/stem cell growth factor receptor Kit
all catalysts(0)
nothing on the calendar yet
Trials studying tivozanib
- phase2Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
- phase2Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma
- phase3Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma
- phase3A Study to Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC)
- phase2A Study of Tivozanib in Combination With Durvalumab in Subjects With Advanced Hepatocellular Carcinoma
News(1)
- Dr McGregor on Key End Points of the STRIKE Trial of Tivozanib Plus Pembrolizumab in RCCBradley McGregor, MD, discusses the end points that will be evaluated in the phase 3 STRIKE trial of adjuvant tivozanib plus pembrolizumab in high-risk RCC.onclive · 3mo ago
Data sources
last refreshed 38m ago
Found something off?
comments(0)
5-min edit window · permanent after that